APA (7th ed.) Citation

Loibl, S., Weber, K., Huober, J., Krappmann, K., Marmé, F., Schem, C., . . . Denkert, C. (2018). Risk assessment after neoadjuvant chemotherapy in luminal breast cancer using a clinicomolecular predictor. Clinical cancer research, 24(14), . https://doi.org/10.1158/1078-0432.CCR-17-2947

Chicago Style (17th ed.) Citation

Loibl, Sibylle, et al. "Risk Assessment After Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor." Clinical Cancer Research 24, no. 14 (2018). https://doi.org/10.1158/1078-0432.CCR-17-2947.

MLA (9th ed.) Citation

Loibl, Sibylle, et al. "Risk Assessment After Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor." Clinical Cancer Research, vol. 24, no. 14, 2018, https://doi.org/10.1158/1078-0432.CCR-17-2947.